Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Celebrex
Active Ingredient: Celecoxib 100mg
Dosage Form: Capsule
New Zealand Sponsor: Pharmacia Limited Company trading as Pharmacia
Manufacturer: Searle Limited, Caguas, Puerto Rico
Product: Celebrex
Active Ingredient: Celecoxib 200mg
Dosage Form: Capsule
New Zealand Sponsor: Pharmacia Limited Company trading as Pharmacia
Manufacturer: Searle Limited, Caguas, Puerto Rico
Product: Minirin
Active Ingredient: Desmopressin acetate 0.1mg equiv to 0.089mg free base
Dosage Form: Tablet
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: PolyPeptide Laboratories AB, Limhamm, Sweden
Product: Minirin
Active Ingredient: Desmopressin acetate 0.2mg equiv to 0.178mg free base
Dosage Form: Tablet
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: PolyPeptide Laboratories AB, Limhamm, Sweden
Product: Zoladex 3.6mg
Active Ingredient: Goserelin acetate 3.6mg
Dosage Form: Subcutaneous implant
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Dated this 28th day of February 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).